AGRF appoints new CEO, Dr Irene Kourtis11 July 2016
Australian Genome Research Facility (AGRF) today announced the appointment of Dr Irene Kourtis as chief executive officer, effective on Monday, 11 July 2016.
AGRF’s chairman, Rob Lewis, said: “The board is delighted an executive of Irene’s calibre has agreed to lead AGRF. Irene has an outstanding reputation for her leadership capabilities, strategic thinking and business acumen. With her deep experience in regulated service industries requiring a strong customer and partner focus, she will lead AGRF’s continued growth and relevance to the Australian genomics community”.
Dr Kourtis said: “I am very excited to lead Australia’s largest full service genomics facility. AGRF has a long history of delivering quality genomics services to its customers, as well as contributing to innovation and development. My goal is to continue that record of strong performance for clients, stakeholders, and collaborators, to play our part in keeping Australia at the innovation forefront.”
Dr Kourtis, was most recently chief executive officer of Children First Foundation: a Melbourne based charity providing life-saving and transformational surgery for children from developing countries. Before joining Children First Foundation, she was the head of enterprise and business development for the Victorian Institute of Forensic Medicine. She joined the Victorian Institute of Forensic Medicine as the business operation manager for forensic scientific services in 2009, and held various leadership, management, and business development roles prior to that.
Dr Kourtis holds a PhD from the MacFarlane Burnet Centre for Medical Research (Burnet Institute) and has over 15 years of experience in research and development in medical and animal health. She is also a graduate of the Australian Institute of Company Directors and holds a graduate diploma in intellectual property law.